Transcriptional Regulation of Motor Neuron Subtype Development

运动神经元亚型发育的转录调控

基本信息

  • 批准号:
    8594715
  • 负责人:
  • 金额:
    $ 4.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-06-21 至 2016-06-20
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Motor neuron circuits control respiration, coordinated movement and sympathetic nervous system activity in vertebrates. A promising treatment for motor neuron degenerative diseases is using cell therapies to replace lost motor neurons. The first step in developing such a treatment will be to create a strategy for directing replacement neurons to form functional motor neuron circuits. During embryonic development, motor neuron circuits are formed through the generation of multiple motor neuron subtypes, which each project to specific muscle targets. Differential gene expression distinguishes distinct motor neuron subtypes and contributes to the differential axon pathfinding of these neurons. It is extremely difficult to isolate individual motor neuron subtypes from intact spinal cords. Because of this challenge, there is relatively little known about the genetic mechanisms that underlie motor neuron subtype specification and axon guidance. The goal of this proposal is to identify novel genes that are differentially expressed in different motor neuron subtypes, and to investigate their functions in the context of motor neuron circuit formation. Preliminary results using a novel technique called 4-Thiouracil (4-TU) tagging, combined with high-throughput RNA-sequencing (RNA-seq), have revealed numerous genes that are enriched in brachial motor neurons compared to thoracic motor neurons. 4-TU tagging uses the cell-type-specific expression of the enzyme Uracil Phosphoribosyl Transferase (UPRT) to label newly synthesized RNAs in specific subsets of cells in the developing spinal cord. Because the brachial spinal cord contains Lateral Motor Column (LMC) neurons and the thoracic spinal cord does not, genes that are enriched in the brachial spinal cord are likely enriched in LMC neurons. Aim1 will investigate LMC specification and axon guidance by first examining the expression of 14 brachial motor neuron genes. From these, I will use genes that are confirmed to be specifically expressed in LMC neurons for gain of function and loss of function experiments. LMC specification will be examined by immunostaining for LMC-specific markers. LMC axon pathfinding will be assessed by labeling motor axons with GFP and through retrograde labeling experiments. Aim 2 will identify novel genes that are differentially expressed in medial LMC (LMCm) neurons and Medial Motor Column (MMCm) neurons, by performing 4-TU tagging and RNA-seq experiments in these two motor neuron subtypes. The expression of 5 putative LMCm and 5 putative MMCm genes will be examined through co-immunostaining for motor neuron subtype specific genes. LCMm and MMCm specific genes will then be used for gain of function and loss of function experiments. Motor neuron subtype specification and axon pathfinding will be assessed by immunostaining for LMCm or MMCm specific markers, labeling motor neuron axons, and through retrograde labeling. These experiments will be the first unbiased examination of motor neuron subtype specific gene expression in developing embryos.
描述(由申请人提供):运动神经元回路控制脊椎动物的呼吸、协调运动和交感神经系统活动。运动神经元退行性疾病的一种有前途的治疗方法是使用细胞疗法来替代丢失的运动神经元。开发这种治疗方法的第一步是创建一种策略来指导替代神经元形成功能性运动神经元回路。在胚胎发育过程中,运动神经元回路是通过产生多种运动神经元亚型而形成的,每种运动神经元亚型都投射到特定的肌肉目标。差异基因表达区分不同的运动神经元亚型,并有助于这些神经元的差异轴突寻路。从完整的脊髓中分离出单个运动神经元亚型是极其困难的。由于这一挑战,人们对运动神经元亚型规范和轴突引导的遗传机制知之甚少。该提案的目标是识别在不同运动神经元亚型中差异表达的新基因,并研究它们在运动神经元回路形成中的功能。使用称为 4-硫尿嘧啶 (4-TU) 标记的新技术与高通量 RNA 测序 (RNA-seq) 相结合的初步结果揭示了与胸运动神经元相比,臂运动神经元中富集的许多基因。 4-TU 标记利用尿嘧啶磷酸核糖转移酶 (UPRT) 的细胞类型特异性表达来标记发育中脊髓的特定细胞亚群中新合成的 RNA。由于臂脊髓含有外侧运动柱 (LMC) 神经元,而胸脊髓不含有,因此在臂脊髓中富集的基因很可能在 LMC 神经元中富集。 Aim1 将首先检查 14 个臂运动神经元基因的表达,以研究 LMC 规范和轴突引导。由此,我将使用已确认在 LMC 神经元中特异性表达的基因进行功能获得和功能丧失实验。 LMC 规格将通过 LMC 特异性标记物的免疫染色进行检查。 LMC 轴突寻路将通过用 GFP 标记运动轴突和逆行标记实验来评估。目标 2 将通过在内侧 LMC (LMCm) 神经元和内侧运动柱 (MMCm) 神经元中进行 4-TU 标记和 RNA-seq 实验来识别这两种运动神经元亚型中差异表达的新基因。将通过运动神经元亚型特异性基因的联合免疫染色来检查 5 个推定的 LMCm 和 5 个推定的 MMCm 基因的表达。然后,LCMm 和 MMCm 特定基因将用于功能获得和功能丧失实验。运动神经元亚型规范和轴突寻路将通过 LMCm 或 MMCm 特异性标记物的免疫染色、标记运动神经元轴突以及通过逆行标记来评估。这些实验将是对发育中胚胎中运动神经元亚型特异性基因表达的首次公正检查。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Madalynn Lea Erb其他文献

Madalynn Lea Erb的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Madalynn Lea Erb', 18)}}的其他基金

Transcriptional Regulation of Motor Neuron Subtype Development
运动神经元亚型发育的转录调控
  • 批准号:
    8713268
  • 财政年份:
    2013
  • 资助金额:
    $ 4.22万
  • 项目类别:
Transcriptional Regulation of Motor Neuron Subtype Development
运动神经元亚型发育的转录调控
  • 批准号:
    8859988
  • 财政年份:
    2013
  • 资助金额:
    $ 4.22万
  • 项目类别:

相似海外基金

Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
  • 批准号:
    MR/Y014901/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
  • 批准号:
    MR/Y014286/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
  • 批准号:
    MR/Y503502/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
  • 批准号:
    2317745
  • 财政年份:
    2023
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Standard Grant
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
  • 批准号:
    10696512
  • 财政年份:
    2023
  • 资助金额:
    $ 4.22万
  • 项目类别:
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
  • 批准号:
    10759808
  • 财政年份:
    2023
  • 资助金额:
    $ 4.22万
  • 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
  • 批准号:
    10848139
  • 财政年份:
    2023
  • 资助金额:
    $ 4.22万
  • 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
  • 批准号:
    10606865
  • 财政年份:
    2023
  • 资助金额:
    $ 4.22万
  • 项目类别:
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
  • 批准号:
    488892
  • 财政年份:
    2023
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Operating Grants
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
  • 批准号:
    MR/Y001095/1
  • 财政年份:
    2023
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Fellowship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了